Cargando…

Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review

A biomarker associated with cognition in neurodegenerative dementias would aid in the early detection of disease progression, complement clinical staging and act as a surrogate endpoint in clinical trials. The current systematic review evaluates the association between cerebrospinal fluid protein ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saunders, Tyler S., Gadd, Danni A., Spires‐Jones, Tara L., King, Declan, Ritchie, Craig, Muniz‐Terrera, Graciela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Special Issue Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790745/ https://www.ncbi.nlm.nih.gov/pubmed/35338546 http://dx.doi.org/10.1111/ejn.15656

Ejemplares similares

Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)
por: Saunders, Tyler S., et al.
Publicado: (2022)

Predictive blood biomarkers and brain changes associated with age-related cognitive decline
por: Saunders, Tyler S, et al.
Publicado: (2023)

Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research
por: Ritchie, Craig W, et al.
Publicado: (2015)

Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study
por: Low, Audrey, et al.
Publicado: (2021)

A comparison of blood and brain‐derived ageing and inflammation‐related DNA methylation signatures and their association with microglial burdens
por: Stevenson, Anna J., et al.
Publicado: (2022)

Application of Big Data and Artificial Intelligence technologies to dementia prevention research: an opportunity for low-and-middle-income countries
por: Danso, Samuel O, et al.
Publicado: (2019)

What matters to people with memory problems, healthy volunteers and health and social care professionals in the context of developing treatment to prevent Alzheimer's dementia? A qualitative study
por: Watson, Julie, et al.
Publicado: (2019)

Assessing and disclosing test results for ‘mild cognitive impairment’: the perspective of old age psychiatrists in Scotland
por: Saunders, Stina, et al.
Publicado: (2022)

Developing an Explainable Machine Learning-Based Personalised Dementia Risk Prediction Model: A Transfer Learning Approach With Ensemble Learning Algorithms
por: Danso, Samuel O., et al.
Publicado: (2021)

Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adults
por: Dounavi, Maria-Eleni, et al.
Publicado: (2022)

Correction to: Assessing and disclosing test results for ‘mild cognitive impairment’: the perspective of old age psychiatrists in Scotland
por: Saunders, Stina, et al.
Publicado: (2022)

A consensus on the classification of hydrocephalus: its utility in the assessment of abnormalities of cerebrospinal fluid dynamics
por: Rekate, Harold L.
Publicado: (2011)

Mobile cognitive testing: opportunities for aging and neurodegeneration research in low- and middle-income countries
por: Muniz-Terrera, Graciela, et al.
Publicado: (2019)

Self‐reported diabetes is associated with allocentric spatial processing in the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study
por: Gregory, Sarah, et al.
Publicado: (2022)

Associations between midlife chronic conditions and medication use with anxiety and depression: A cross-sectional analysis of the PREVENT Dementia study
por: Stirland, Lucy E, et al.
Publicado: (2020)

Educational inequalities in aging-related declines in fluid cognition and the onset of cognitive pathology
por: Clouston, Sean A.P., et al.
Publicado: (2015)

Cognitive Decline and Dementia in the Oldest-Old
por: Kravitz, Efrat, et al.
Publicado: (2012)

Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression
por: Christine, Chadwick W., et al.
Publicado: (2020)

Understanding and predicting the longitudinal course of dementia
por: Melis, René J.F., et al.
Publicado: (2019)

Duration of Reproductive Period and Risk of Transitioning to Mild Cognitive Impairment and Dementia
por: Yoneda, Tomiko, et al.
Publicado: (2021)

Duration of Reproductive Period and Risk of Transitioning to Mild Cognitive Impairment and Dementia
por: Knight, Jamie, et al.
Publicado: (2021)

Comparison of Cox proportional hazards regression and generalized Cox regression models applied in dementia risk prediction
por: Goerdten, Jantje, et al.
Publicado: (2020)

Differences in the longitudinal change of behaviours related to dementia in long-term care: a growth mixture modelling approach
por: Robitaille, Annie, et al.
Publicado: (2023)

Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia study
por: Dounavi, Maria-Eleni, et al.
Publicado: (2021)

Cerebrospinal fluid catecholamines in delirium and dementia
por: Henjum, Kristi, et al.
Publicado: (2021)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2021)

Virtual Cohorts and Synthetic Data in Dementia: An Illustration of Their Potential to Advance Research
por: Muniz-Terrera, Graciela, et al.
Publicado: (2021)

Cerebrospinal Fluid Production and Absorption and Ventricular Enlargement Mechanisms in Hydrocephalus
por: YAMADA, Shigeki, et al.
Publicado: (2023)

Cognitive Dispersion Predicts Grip Strength Trajectories in Men but not Women in a Sample of the Oldest Old Without Dementia
por: Watermeyer, Tamlyn, et al.
Publicado: (2021)

Motoric Cognitive Risk Syndrome: Its prognostic value for dementia and other health outcomes. A systematic review
por: Mullin, Donncha, et al.
Publicado: (2021)

Motoric Cognitive Risk Syndrome: Its prognostic value for dementia and other health outcomes. A systematic review
por: Mullin, Donncha, et al.
Publicado: (2021)

Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program
por: Saunders, Stina, et al.
Publicado: (2018)

Treatment Strategies and Challenges to Avoid Cerebrospinal Fluid Shunting for Pediatric Hydrocephalus
por: PARK, Young-Soo
Publicado: (2022)

Automated Segmentation of Retinal Fluid Volumes From Structural and Angiographic Optical Coherence Tomography Using Deep Learning
por: Guo, Yukun, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes
por: Trotti, Lynn Marie, et al.
Publicado: (2021)

Hormonal contraception and risk for cognitive impairment or Alzheimer's disease and related dementias in young women: a scoping review of the evidence
por: Gregory, Sarah, et al.
Publicado: (2023)

Mediterranean diet score is associated with greater allocentric processing in the EPAD LCS cohort: A comparative analysis by biogeographical region
por: Gregory, Sarah, et al.
Publicado: (2022)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2022)

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
por: Niemela, Valter, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r3k1v4q73v1h2tbg9gbbelhuhi